ASTEX PHARMACEUTICALS, INC Net Cash Provided by (Used in) Continuing Operations
ASTEX PHARMACEUTICALS, INC reported Net Cash Provided by (Used in) Continuing Operations of $20.15 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for the quarter ending 2013-06-30 was -$26.09M.
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for the quarter ending 2013-03-31 was $46.23M.
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for the quarter ending 2012-12-31 was -$11.28M, a 709.84% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for the quarter ending 2012-09-30 was $434.00K, a 94.51% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for fiscal 2012 was -$24.29M, a 270.66% decline from fiscal 2011.
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for fiscal 2011 was $14.23M, a 20.36% decline from fiscal 2010.
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for fiscal 2010 was $17.87M.
- ASTEX PHARMACEUTICALS, INC net cash provided by (used in) continuing operations for fiscal 2009 was -$41.23M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$26.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $20.15M 10-Q · filed 2013-08-09 | $8.87M derived: sum of 3 quarters · filed 2013-08-09 | $9.31M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $46.23M 10-Q · filed 2013-05-10 | $34.96M derived: sum of 2 quarters · filed 2013-05-10 | $35.39M derived: sum of 3 quarters · filed 2013-05-10 | $27.05M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | -$11.28M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$10.84M derived: sum of 2 quarters · filed 2013-03-18 | -$19.19M derived: sum of 3 quarters · filed 2013-08-09 | -$24.29M 10-K · filed 2013-03-18 |
| 2012-09-30 | $434.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$7.91M derived: sum of 2 quarters · filed 2013-08-09 | -$13.02M 10-Q · filed 2012-11-09 | -$11.17M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | -$8.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$13.45M 10-Q · filed 2013-08-09 | -$11.60M derived: sum of 3 quarters · filed 2013-08-09 | -$3.69M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | -$5.10M 10-Q · filed 2013-05-10 | -$3.25M derived: sum of 2 quarters · filed 2013-05-10 | $4.66M derived: sum of 3 quarters · filed 2013-05-10 | $9.87M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $9.76M derived: sum of 2 quarters · filed 2013-03-18 | $14.97M derived: sum of 3 quarters · filed 2013-03-18 | $14.23M 10-K · filed 2013-03-18 |
| 2011-09-30 | $7.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $13.12M derived: sum of 2 quarters · filed 2012-11-09 | $12.38M 10-Q · filed 2012-11-09 | $25.06M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.47M 10-Q · filed 2012-08-09 | $17.15M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2011-03-31 | -$737.00K 10-Q · filed 2012-05-10 | $11.94M derived: sum of 2 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $12.67M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $17.87M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $5.20M 10-Q · filed 2011-11-09 | |||
| 2009-12-31 | -$41.23M 10-K · filed 2012-03-15 |